JPMorgan Chase & Co’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.7M | Buy |
356,607
+345,012
| +2,976% | +$32.6M | ﹤0.01% | 1429 |
|
|
2025
Q1 | $736K | Sell |
11,595
-1,268
| -10% | -$80.5K | ﹤0.01% | 3818 |
|
|
2024
Q4 | $597K | Sell |
12,863
-1,197
| -9% | -$55.6K | ﹤0.01% | 4070 |
|
|
2024
Q3 | $405K | Buy |
14,060
+3,696
| +36% | +$106K | ﹤0.01% | 4143 |
|
|
2024
Q2 | $150K | Sell |
10,364
-7,277
| -41% | -$105K | ﹤0.01% | 4408 |
|
|
2024
Q1 | $284K | Buy |
17,641
+4,882
| +38% | +$78.6K | ﹤0.01% | 4267 |
|
|
2023
Q4 | $254K | Buy |
12,759
+47
| +0.4% | +$934 | ﹤0.01% | 4303 |
|
|
2023
Q3 | $207K | Buy |
12,712
+9,559
| +303% | +$156K | ﹤0.01% | 4219 |
|
|
2023
Q2 | $66.7K | Sell |
3,153
-214,417
| -99% | -$4.53M | ﹤0.01% | 4793 |
|
|
2023
Q1 | $4.37M | Buy |
217,570
+215,639
| +11,167% | +$4.33M | ﹤0.01% | 2540 |
|
|
2022
Q4 | $50K | Sell |
1,931
-61,348
| -97% | -$1.59M | ﹤0.01% | 4741 |
|
|
2022
Q3 | $647K | Buy |
+63,279
| New | +$647K | ﹤0.01% | 3599 |
|
|
2021
Q2 | – | Sell |
-35
| Closed | – | – | 5659 |
|
|
2021
Q1 | $0 | Sell |
35
-348
| -91% | – | ﹤0.01% | 5395 |
|
|
2020
Q4 | $3K | Buy |
+383
| New | +$3K | ﹤0.01% | 4768 |
|